M.C. Carrara

401 total citations
13 papers, 323 citations indexed

About

M.C. Carrara is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, M.C. Carrara has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Biochemistry and 4 papers in Molecular Biology. Recurrent topics in M.C. Carrara's work include Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (3 papers). M.C. Carrara is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Nitric Oxide and Endothelin Effects (3 papers). M.C. Carrara collaborates with scholars based in Canada, Italy and United States. M.C. Carrara's co-authors include C.R. Pace-Asciak, K. C. Nicolaou, Godha Rangaraj, A. Jori, Lawrence Levine, A. D. Baines, K.C. Nicolaou and Silvio Garattini and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cellular and Molecular Life Sciences and Progress in Lipid Research.

In The Last Decade

M.C. Carrara

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Carrara Canada 9 174 161 74 73 50 13 323
C P Quilley United States 11 79 0.5× 79 0.5× 72 1.0× 79 1.1× 44 0.9× 17 314
Earl W. Dunham United States 11 113 0.6× 85 0.5× 65 0.9× 147 2.0× 58 1.2× 26 390
Krairerk Athirakul United States 7 152 0.9× 205 1.3× 86 1.2× 141 1.9× 95 1.9× 15 467
P D Dawkins United States 12 124 0.7× 50 0.3× 39 0.5× 140 1.9× 22 0.4× 19 452
M Tsuboshima Japan 9 112 0.6× 50 0.3× 163 2.2× 109 1.5× 34 0.7× 12 443
Gryglewski Rj Poland 9 70 0.4× 52 0.3× 93 1.3× 59 0.8× 23 0.5× 40 307
P. YADAGIRI United States 8 117 0.7× 348 2.2× 113 1.5× 136 1.9× 123 2.5× 10 504
F. B. Ubatuba United Kingdom 10 202 1.2× 161 1.0× 80 1.1× 145 2.0× 52 1.0× 15 573
Paul J. DeSchepper United States 7 273 1.6× 80 0.5× 62 0.8× 31 0.4× 14 0.3× 8 396
M. Oka Canada 10 64 0.4× 52 0.3× 50 0.7× 65 0.9× 43 0.9× 20 325

Countries citing papers authored by M.C. Carrara

Since Specialization
Citations

This map shows the geographic impact of M.C. Carrara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Carrara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Carrara more than expected).

Fields of papers citing papers by M.C. Carrara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Carrara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Carrara. The network helps show where M.C. Carrara may publish in the future.

Co-authorship network of co-authors of M.C. Carrara

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Carrara. A scholar is included among the top collaborators of M.C. Carrara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Carrara. M.C. Carrara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pace-Asciak, C.R., M.C. Carrara, & Lawrence Levine. (1981). PGI2 is not a circulating vasodepressor hormone. Progress in Lipid Research. 20. 113–116. 1 indexed citations
2.
Pace-Asciak, C.R., M.C. Carrara, Lawrence Levine, & K.C. Nicolaou. (1980). PGI2-specific antibodies administered suggest against a role for endogenous PGI2 as a circulating vasodepressor hormone in the normotensive and spontaneously hypertensive rat. Prostaglandins. 20(6). 1053–1060. 19 indexed citations
3.
Pace-Asciak, C.R., M.C. Carrara, & Lawrence Levine. (1980). Antibodies to 5,6-dihydroprostaglandin I2 trap endogenously produced prostaglandin I2 in the rat circulation. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 620(2). 186–192. 6 indexed citations
4.
Pace-Asciak, C.R. & M.C. Carrara. (1979). Age-dependent increase in the formation of prostaglandin I2 by intact and homogenised aortae from the developing spontaneously hypertensive rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 574(1). 177–181. 29 indexed citations
5.
Pace-Asciak, C.R. & M.C. Carrara. (1979). Reduction in dietary vitamin E prevents onset of hypertension in developing spontaneously hypertensive rats. Cellular and Molecular Life Sciences. 35(12). 1561–1562. 3 indexed citations
6.
Pace-Asciak, C.R., M.C. Carrara, Godha Rangaraj, & K. C. Nicolaou. (1978). Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat. Prostaglandins. 15(6). 1005–1012. 117 indexed citations
7.
Pace-Asciak, C.R., M.C. Carrara, & K. C. Nicolaou. (1978). Prostaglandin I2 has more potent hypotensive properties than prostaglandin E2 in the normal and spontaneously hypertensive rat. Prostaglandins. 15(6). 999–1003. 53 indexed citations
9.
Pace-Asciak, C.R., et al.. (1977). Catabolism of 6-ketoprostaglandin F1α by the rat kidney cortex. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 487(2). 400–404. 10 indexed citations
10.
Pace-Asciak, C.R., et al.. (1977). Identification of the major urinary metabolites of 6-ketoprostaglandin F1α (6K-PGF1α) in the rat. Biochemical and Biophysical Research Communications. 78(1). 115–121. 48 indexed citations
11.
Carrara, M.C. & A. D. Baines. (1976). Propranolol induces acute natriuresis by β blockade and dopaminergic stimulation. Canadian Journal of Physiology and Pharmacology. 54(5). 683–691. 9 indexed citations
12.
Jori, A., M.C. Carrara, & Silvio Garattini. (1966). Importance of noradrenaline synthesis for the interaction between desipramine and reserpine. Journal of Pharmacy and Pharmacology. 18(9). 619–620. 11 indexed citations
13.
Jori, A. & M.C. Carrara. (1966). On the mechanism of the hyperglycaemic effect of chlorpromazine. Journal of Pharmacy and Pharmacology. 18(9). 623–624. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026